Enigma Biomedical USA Announces FDA Approval of TAUKLARIFY™ (florquinitau F 18 injection) for Use in Patients Being Evaluated for Alzheimer’s Disease

Originally published by Financial Post — read the full article at the source →

Shown as published in the source's RSS feed. Formatting and images are simplified for readability here — follow the source link above for the original article.